Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients Publisher Pubmed



Hatef B1 ; Pirzad Jahromi G1 ; Meftahi GH1 ; Shaygan V2 ; Ghalavand M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neuroscience Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Neuropsychological Rehabilitation Published:2023


Abstract

This study aimed to compare the changes in psychological status and cortisol level between multiple sclerosis (MS) patients and a healthy control group (HC). One hundred and fifty-five MS patients and 165 HC subjects had completed questionnaires consisting of 36-Item short health survey (SF-36), Hamilton Anxiety Rating Scale (HAM-A), Beck Depression Inventory-II (BDI-II), and fatigue severity score (FSS) before and after (one year from onset) COVID-19 pandemic. The salivary cortisol level was also measured again in 26 MS patients and 14 control individuals. MS patients had lower scores of mental and physical components of quality of life (MCS and PCS), but higher HAM-A, FSS, and BDII scores than HC Before and after COVID-19. There were significant changes in scores of MCS, BDI-II, HAM-A, and FSS after the COVID-19 outbreak in MS patients, but not in PCS score. In HC group, we observed significant changes in scores of MCS, BDI-II, and FSS, but not in scores of PCS and HAM-A. Compared to HC, the MS patients reported greater deterioration in the overall mental health component of their health-related quality of life, and their levels of anxiety and fatigue over the study period. The change of cortisol levels was non-significant with a small effect size. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Fear of Relapse, Social Support, and Psychological Well-Being (Depression, Anxiety, and Stress Level) of Patients With Multiple Sclerosis (Ms) During the Covid-19 Pandemic Stage, Neurological Sciences (2021)
2. Assessment of Mental Health, Knowledge, and Attitude of Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Response to 2019 Novel Coronavirus, Neurological Sciences (2021)
3. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
4. Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of Covid-19 in Multiple Sclerosis: A Menactrims Registry Based Study, Multiple Sclerosis and Related Disorders (2024)
5. Fear and Anxiety in Patients With Multiple Sclerosis During Covid-19 Pandemic; Report of an Iranian Population, Multiple Sclerosis and Related Disorders (2021)
6. A Multi-Centre Longitudinal Study Analysing Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns During the Covid-19 Pandemic, Journal of Neurology (2024)
7. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
8. Fear of Re-Infection, Relapse, and Anxiety During Covid-19 Pandemic in Patients With Multiple Sclerosis: A Multi-Center Study, Current Journal of Neurology (2023)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (113)
Masoud Etemadifar (67)
Other Related Docs
9. Social Support and Anxiety Correlation With Resilience in Patients With Multiple Sclerosis During Covid-19 Pandemic, Current Journal of Neurology (2023)
10. Potential of Modified Mediterranean Diet to Improve Quality of Life and Fatigue Severity in Multiple Sclerosis Patients: A Single-Center Randomized Controlled Trial, International Journal of Food Properties (2020)
11. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
12. Multiple Sclerosis Is Associated With Worse Covid-19 Outcomes Compared to the General Population: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
13. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
14. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
15. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
16. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)
17. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
18. Covid-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight With No Bystander Effect?, Multiple Sclerosis and Related Disorders (2021)
19. Assessment of Intelligence Quotient in Patients With Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
20. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
21. Association of Dietary Patterns With Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in Ms Patients, Nutritional Neuroscience (2020)
22. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
23. Covid-19 Susceptibility and Outcomes Among Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2022)
24. Emotional Competencies in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
25. The Effect of Group Cognitive Behavioral Therapy on Stress, Anxiety, and Depression of Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2017)
26. Evaluation of Cognitive Rehabilitation on the Cognitive Performance in Multiple Sclerosis: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2019)
27. Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis Compared to Healthy Adolescents and Young Adults, Neuropsychiatric Disease and Treatment (2016)
28. Compared to an Active Control Condition, in Persons With Multiple Sclerosis Two Different Types of Exercise Training Improved Sleep and Depression, But Not Fatigue, Paresthesia, and Intolerance of Uncertainty, Multiple Sclerosis and Related Disorders (2019)
29. Effects of Acceptance and Commitment Therapy (Act) and Mindfulness-Based Stress Reduction (Mbsr) on Symptoms and Emotional Competencies in Individuals With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
30. Short Report: Assessment of Coping Strategies in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd) and Multiple Sclerosis, Psychology, Health and Medicine (2022)
31. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
32. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
33. Prevalence and Risk Factors of Dysphagia in Patients With Multiple Sclerosis, Dysphagia (2022)
34. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
35. Risk of Depression After Parkinson's Disease, Stroke, Multiple Sclerosis, and Migraine in an Iranian Population and Assess Psychometric Characteristics of Three Prevalent Depression Questionnaires, IBRO Neuroscience Reports (2024)
36. Risk Factors of Severe Covid-19 in People With Multiple Sclerosis : A Systematic Review and Meta-Analysis, Revue Neurologique (2022)
37. Comparing Body Image in Ms Patients and Healthy Individuals, International Journal of Body, Mind and Culture (2020)
38. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
39. Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients, International Journal of Preventive Medicine (2023)
40. Multiple Sclerosis and Personality Traits: Associations With Depression and Anxiety, European Journal of Medical Research (2024)
41. Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial, International Journal of Preventive Medicine (2020)
42. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
43. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
44. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
45. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
46. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
47. Comparison of Cognitive Rehabilitation Versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression Among Multiple Sclerosis Patients, Neurology Research International (2020)
48. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
49. A Mediterranean-Type Diet Improved Systemic Inflammation in Multiple Sclerosis Patients, As Compared to the Traditional Iranian Diet: A Single-Center Randomized Controlled Trial, Mediterranean Journal of Nutrition and Metabolism (2021)
50. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018, CNS Drugs (2021)